During a press conference in the White House, Novo Nordisk executive Gordon Findlay unexpectedly collapsed while standing behind President Donald Trump. The event was held to announce a new deal concerning weight-loss medications.
Suddenly, Findlay's knees gave way, and administration officials along with pharmaceutical representatives quickly intervened to prevent him from falling to the floor.
White House Press Secretary Karoline Leavitt confirmed the incident during the "Most Favored Nations Oval Office Announcement." She explained that a company representative fainted but was attended to promptly by on-site medical personnel.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Press witnesses reported that Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, assisted Findlay to the ground to prevent head injury. Afterward, reporters were escorted out of the Oval Office so cabinet members could attend to Findlay and elevate his legs.
The press conference was set to resume shortly after the medical incident.
“The Press Conference will resume shortly.”
Author’s summary: A Novo Nordisk executive fainted during a White House press event with President Trump but received immediate medical assistance and recovered quickly, allowing the event to continue.